Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00827801 · ClinicalTrials.gov registry record
M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program
A clinical trial of Cancer and Heart Failure, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT00827801: Completed study of Cancer and Heart Failure, sponsored by M.D. Anderson Cancer Center.
NCT00827801 is a study of Cancer and Heart Failure that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 26 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00827801, a study of Cancer and Heart Failure, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective: To determine if there is a reduction in the mean symptom severity scores for the heart failure specific symptom items between baseline and at the end of three months between patients whose symptoms are managed using the MDASI-HF symptom assessment scores (treatment group) as a decision making guide, as compared to patients managed without using the MDASI-HF symptom assessment scores (control group). Secondary Objectives: 1. Examine the correlation between mean symptom severity scores and the secondary endpoints of: a) exercise tolerance ( 6-minute walk), b) NYHA (New York Heart Association) functional classification, c) B-type natriuretic peptide (a biomarker for heart failure), and d) dose titration of HF (heart failure) medications. 2. Define symptom severity critical values in cancer patients with concurrent heart failure that trigger clinical intervention 3. Identify symptom clusters which may occur in cancer patients with concurrent heart failure.
Conditions Studied
Interventions
- BEHAVIORAL MDASI-HF Questionnaire
Study Locations (1)
Texas
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-08 |
What the finished NCT00827801 record still lists
NCT00827801 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which MDASI-HF Questionnaire is the first listed.
NCT00827801 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00827801 about?
NCT00827801 is a clinical study titled "M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program". Primary Objective: To determine if there is a reduction in the mean symptom severity scores for the heart failure specific symptom items between baseline and at the end of three months between patients whose symptoms are managed using the MDASI-HF symptom assessment scores (treatment group) as a de...
What is the current status of trial NCT00827801?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2009-01. Estimated completion is 2011-08.
What conditions does trial NCT00827801 study?
This clinical trial studies the following conditions: Cancer, Heart Failure.
What interventions are being tested in trial NCT00827801?
The interventions under investigation include: MDASI-HF Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00827801?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00827801 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00827801's enrollment target sits among peer trials
26 532nd of 615 higher than 80 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia